Bioequivalence Study of Two Formulations of Telmisartan 80 mg Tablets in Healthy Adult Volunteers Under Fasting State
Clinical trial NCT03705533 · COMPLETED
Trial details
- NCT number
- NCT03705533
- Sponsor
- Pharmtechnology LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-07
- Primary completion
- 2018-12-16
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.